Should vascular catheters be removed from all patients with candidemia? An evidence-based review.
about
Central venous catheter (CVC) removal for adult patients with candidaemiaCentral venous catheter (CVC) removal for patients of all ages with candidaemiaAlcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanismECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsInteractions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.In vivo inhibitory effect on the biofilm formation of Candida albicans by liverwort derived riccardin D.Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serumVascular catheter-associated infections: a microbiological and therapeutic update.Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.Catheter-related bloodstream infections, part II: specific pathogens and prevention.Changing strategies for the management of invasive fungal infections.Candida infections of medical devices.Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014.Candida Associated Bloodstream Infections in Pediatric Hematology Patients: A Single Center Experience.Treatment options in candidaemia.Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome.Management of catheter-related infection.Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.Determinants of mortality in non-neutropenic ICU patients with candidaemiaDevelopment and characterization of an in vivo central venous catheter Candida albicans biofilm model.Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009.The management of Candida infections in preterm neonates and the role of micafungin.Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study.Risk factors for candidemia in pediatric intensive care unit patients.Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland.Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.Adherence to clinical practice guidelines for the treatment of candidemia at a Veterans Affairs Medical Center.Is biofilm production a predictor of catheter-related candidemia?Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.Epidemiology and management of candidaemia--a retrospective, multicentre study in five hospitals in the UK.Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections.Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates.Factors prompting early central venous catheter removal from cancer patients with candidaemia.Development of New Strategies for Echinocandins: Progress in Translational Research.Invasive fungal infections at The Norwegian Radium Hospital 1998-2003.Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials.An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.
P2860
Q24195090-E313DD33-AB33-437F-AD82-E288FDF5767CQ26471135-1601E446-9FD5-4F15-88F5-9C926B799601Q33247523-49441BB2-BF2C-414E-8FB2-7295B3EA1FB2Q33573788-5F623A3D-A2B1-4659-9991-2B84BA976F18Q34024546-529AB839-F51F-47D4-9103-C2815F864FF1Q34251150-07272F5C-5D47-4832-B69D-9A0C0ED2A0A4Q34454950-F161CB83-8EE7-4085-9104-172E30D2BB50Q34585059-D3DC05F5-A269-4C26-ABC9-72B010D1D90CQ34932922-206FED3F-0408-4DCC-AB4A-9BBED8A8F1CBQ35071110-21D889F9-EC10-489A-9047-C8CD4B012DBEQ35678997-A1B08F13-F9CA-4BB4-BD8E-7FF07AD556CFQ35745818-0F7841A7-C61B-4729-AFFB-AD09F68FDB38Q36094887-53FAD302-5895-4E91-8DEC-A9A51B4B8E17Q36241645-732DD9E8-5DFD-47DC-927F-E9856F3B5C3BQ36630796-E440309C-3746-43DC-A73F-92B96F8F16C2Q36774262-B7C56C96-ED30-4DB9-BCBB-E5F595815384Q36822025-9346325B-A997-467E-9742-7762BEAEBFB4Q37077615-AB980619-CDA9-4662-A3FC-C08F2BF635FFQ37122502-D718B4CF-C2D8-44AE-BA72-9F890C4EAE8CQ37360312-E369EE22-C6CA-4BD8-8CAE-B13FF6F2B7B7Q37523933-511D8B1D-80AB-4420-8E8D-0D69F9F90549Q37734765-28B456E5-6D8B-45F5-94D1-265FB748A2F6Q37873554-3BE14B37-8E88-48D4-A647-4EDB1E6A1973Q37900293-29100529-76E9-4AF7-8ED3-01143D5C9E84Q38633105-45C5FB87-6463-4C14-888B-02F5BD563AB8Q39198462-44DFB568-308A-46ED-9ED2-D096977DE3D9Q39232717-209101FB-CC72-48B4-9EB5-FD73B9226B6AQ40513183-9DAD86C7-9B3F-4095-BF66-AAD8360488A4Q40748882-F2B71247-C993-4D0A-B390-7D181F455404Q41706308-71DA6C63-CBB5-4D88-AA98-7B3075C0BEDFQ42217263-ED378B80-959B-4E72-9DA0-BEBB2802EBBDQ42233832-7633CB9E-E560-4E9C-99CF-6068B149EBB5Q43766112-74091CCF-C64B-4B3A-AEBD-70837313568CQ44830700-C8DE66F5-36B0-4151-B0AC-DAA7030C48FDQ46021266-76AB4FD9-2D3D-4658-92E7-C505E4770D6EQ46247251-E91C8F3B-E346-4A90-A8B4-D8740BD29791Q46639635-AE0281EB-C8C4-45FB-BBC0-66ACA2A2DAE2Q46683505-FDFE2621-A79F-4043-B1D3-5BDD0849CACAQ46714480-461D942B-91E4-4911-90D1-4EB2F506B41DQ54394711-A992D8AD-3FAC-4F3C-87CF-660549209565
P2860
Should vascular catheters be removed from all patients with candidemia? An evidence-based review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Should vascular catheters be r ...... mia? An evidence-based review.
@ast
Should vascular catheters be r ...... mia? An evidence-based review.
@en
Should vascular catheters be r ...... mia? An evidence-based review.
@nl
type
label
Should vascular catheters be r ...... mia? An evidence-based review.
@ast
Should vascular catheters be r ...... mia? An evidence-based review.
@en
Should vascular catheters be r ...... mia? An evidence-based review.
@nl
prefLabel
Should vascular catheters be r ...... mia? An evidence-based review.
@ast
Should vascular catheters be r ...... mia? An evidence-based review.
@en
Should vascular catheters be r ...... mia? An evidence-based review.
@nl
P2860
P356
P1476
Should vascular catheters be r ...... mia? An evidence-based review.
@en
P2860
P304
P356
10.1086/338714
P407
P577
2002-01-24T00:00:00Z